Xiyi Chen
Nanjing, 210004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
IGF2BP2 promotes malignant progression of ovarian cancer by regulating protein synthesis through liquid-liquid phase separation.
Journal: Cell reports
Published: February 18, 2025
Tumor biomarkers contribute to the diagnosis and clinical management of the O-RADS MRI risk stratification system for epithelial ovarian tumors.
Journal: World journal of surgical oncology
Published: September 11, 2024
LncRNA SLC25A21-AS1 increases the chemosensitivity and inhibits the progression of ovarian cancer by upregulating the expression of KCNK4.
Journal: Functional & integrative genomics
Published: January 18, 2023
Long noncoding RNA RFPL1S-202 inhibits ovarian cancer progression by downregulating the IFN-β/STAT1 signaling.
Journal: Experimental cell research
Published: April 28, 2022
Deep Grouping Analysis of the Altered Cervical Canal Microbiota in Intrauterine Adhesion Patients.
Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: March 10, 2022
Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer.
Journal: Journal of ovarian research
Published: October 15, 2021
The Regulation Network and Clinical Significance of Circular RNAs in Breast Cancer.
Journal: Frontiers in oncology
Published: April 06, 2021
Coexisting CLT in PTC is an independent predictor of tumor aggressiveness for patients aged under 55: a retrospective analysis of 635 patients.
Journal: BMC endocrine disorders
Published: March 22, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026